je.st
news
Johnson & Johnson (JNJ) Upgraded at Goldman Sachs
2016-03-27 03:18:04| Biotech - Topix.net
The firm currently has a $112.00 price objective on the stock, up from their previous price objective of $102.00. Goldman Sachs' price target indicates a potential upside of 3.41% from the stock's current price.
Tags: johnson
upgraded
goldman
sachs
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||